In our previous study, the presence of PD-L1+ CSCs in metastatic LNs in lung cancer patients was confirmed, which may suggest their importance in the cross-talk with PD-1+ immune cells and immunosuppressive properties [11]. The gene discussed is CD274; the disease is lung carcinoma.